NCT05466825 The Global Cardiovascular Risk Consortium
| NCT ID | NCT05466825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | All-cause Mortality |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000,000 participants |
| Start Date | 2019-09-20 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000,000 participants in total. It began in 2019-09-20 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Global Cardiovascular Risk Consortium (GCVRC) brings together harmonized individual-level data from currently more than 2 million (anticipated: approximately 3 million) individuals across 133 cohorts, 40 countries, and 6 continents, with recruitment ongoing. The GCVRC examines the impact of classical cardiovascular risk factors-such as body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes-on cardiovascular disease (CVD) and death from any cause worldwide.
Eligibility Criteria
Inclusion Criteria: Population-based individual-level data with available information on the classical cardiovascular risk factors including body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes, as well as the outcomes of interest. Exclusion Criteria: * Participants with age below 18 years * No information on the outcome of interest * No information on the exposure of interest (CVD risk factors) * History of CVD at baseline
Contact & Investigator
Prof. Dr. med. Stefan Blankenberg
STUDY CHAIR
Universitätsklinikum Hamburg-Eppendorf
Frequently Asked Questions
Who can join the NCT05466825 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying All-cause Mortality. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05466825 currently recruiting?
Yes, NCT05466825 is actively recruiting participants. Contact the research team at s.blankenberg@uke.de for enrollment information.
Where is the NCT05466825 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT05466825 clinical trial?
NCT05466825 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The principal investigator is Prof. Dr. med. Stefan Blankenberg at Universitätsklinikum Hamburg-Eppendorf. The trial plans to enroll 3,000,000 participants.